Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TG7I
|
|||
| Former ID |
DIB004280
|
|||
| Drug Name |
Erythromycin/sulfisoxazole
|
|||
| Synonyms |
Erythromycin & AC1L9V78; (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4- [(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L- ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13- trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6- trideoxy-3-; 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Gram-positive bacterial infection [ICD-11: 1B74-1G40] | Approved | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C48H80N4O16S
|
|||
| Canonical SMILES |
CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N
|
|||
| InChI |
1S/C37H67NO13.C11H13N3O3S/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;3-6,14H,12H2,1-2H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;/m1./s1
|
|||
| InChIKey |
LUDXWSVNRXAANN-YZPBMOCRSA-N
|
|||
| CAS Number |
CAS 83047-45-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.